Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-762P is a pseudogene related to the gene encoding U6 small nuclear RNA (snRNA), which is an essential non-coding RNA component of the spliceosome, the large ribonucleoprotein complex responsible for removing introns from pre-mRNA in eukaryotes[1][3]. Pseudogenes such as RNU6-762P retain sequence similarity to the functional snRNA genes but have lost the ability to produce functional RNA due to mutations or truncations[7][6][4]. RNU6-762P itself does not produce a mature snRNA or play a direct biological role; instead, it exists as a non-functional genomic sequence. Pseudogenes of U6 snRNA are common in the vertebrate genome and have sometimes been used as reference sequences in genomic studies[5][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 762, pseudogene (RNU6-762P).